| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 43 |
| 1 | RENAL IMPAIRMENT | 42 |
| 2 | DEATH | 35 |
| 3 | OFF LABEL USE | 34 |
| 4 | CEREBROVASCULAR ACCIDENT | 27 |
| 5 | FATIGUE | 27 |
| 6 | HEADACHE | 27 |
| 7 | NAUSEA | 24 |
| 8 | PAIN | 23 |
| 9 | DYSPNOEA | 22 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | VISUAL MIDLINE SHIFT SYNDROME | 1 | 0.2500 |
| 1 | GLOBOTRIAOSYLSPHINGOSINE INCREASED | 5 | 0.0255 |
| 2 | ANGIOKERATOMA | 2 | 0.0235 |
| 3 | OROPHARYNGEAL SURGERY | 1 | 0.0222 |
| 4 | THERMOHYPOAESTHESIA | 1 | 0.0132 |
| 5 | RIGHT ATRIAL ENLARGEMENT | 2 | 0.0101 |
| 6 | VENTRICULAR DYSKINESIA | 2 | 0.0096 |
| 7 | INFERIOR VENA CAVA DILATATION | 2 | 0.0095 |
| 8 | IMPLANTABLE CARDIAC MONITOR INSERTION | 1 | 0.0088 |
| 9 | CEREBROSPINAL FLUID RETENTION | 1 | 0.0085 |